Eric Yoo, Pharm.D. Vice President

Eric Yoo, Pharm.D., is a Vice President at HCRx. Dr. Yoo primarily supports HCRx’s investment research efforts and works across the firm’s business development and transaction-related activities, including financial analysis, transaction structuring, and due diligence. Prior to joining HCRx, Dr. Yoo was Director of Research & Investments at DRI Healthcare (DRI Capital), where he focused on royalty and equity investments. Earlier in his career, he served as a biotechnology equity research analyst at Stifel Europe (formerly Bryan, Garnier & Co.) in London, covering European SMID-cap biotechnology equities, and as an investment analyst at Third Eye Asset Management, a global biotechnology long/short equity hedge fund. Dr. Yoo earned his Doctor of Pharmacy (Pharm.D.) and Bachelor of Science (B.Sc.) degrees from the University of Waterloo.